NCT07889232
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07889232
Title Tocilizumab Combined With First-Line Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer (TOCI)
Acronym TOCI
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors VA Office of Research and Development
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Richard L. Roudebush VA Medical Center, Indianapolis, IN Indianapolis Indiana 46202-2884 United States Details
VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor Michigan 48105-2303 United States Details
Louis Stokes VA Medical Center, Cleveland, OH Cleveland Ohio 44106-1702 United States Details
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA Pittsburgh Pennsylvania 15240 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field